BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5158278)

  • 1. [Clinical experiences with a new anabolic steroid: 2-formyl-17(alpha)methylandrosta-1,4-dien-11(alpha)17(beta)diol-3-one].
    Pardini C; Terreni F
    Clin Ter; 1971 Aug; 58(4):343-50. PubMed ID: 5158278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human pharmacological study of quinbolone. Clinical and laboratory investigations of the effects of anabolic treatment in aged women].
    Mezzena R; Foresti M; Trisotto M; Bruni G
    G Gerontol; 1972 Apr; 20(4):361-78. PubMed ID: 5042390
    [No Abstract]   [Full Text] [Related]  

  • 3. [N, Ca and P balance in humans after oral administration of a new anabolic steroid, 2-formyl-17 alpha methylandrosta-1,4-dien-11 alpha-17 beta-diol-3-one].
    Vaccari A; Livini E
    Minerva Med; 1971 Feb; 62(17):846-51. PubMed ID: 5551773
    [No Abstract]   [Full Text] [Related]  

  • 4. 17 beta-hydroxy-4-estren-3-one laurate, a new long-acting anabolic steroid.
    Vermeulen HJ
    Arzneimittelforschung; 1968 Nov; 18(11):1458-60. PubMed ID: 5755913
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of deficiency syndromes in the aged].
    Pasgualicchio A; Pasoli CA; Forte PL; Corbellari GC
    Minerva Med; 1972 Jun; 63(43):2425-30. PubMed ID: 4504024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Clinical evaluation of a new protein anabolic steroid, 2 alpha-3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1, -methoxycyxlopentyl ether (10364-S)].
    Iwai K; Honda H; Yamada S; Fukase M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):501. PubMed ID: 4476529
    [No Abstract]   [Full Text] [Related]  

  • 7. Androstane derivative devoid of anabolic-virilizing effects and endowed with an antiglucocorticoid activity.
    Berti F; Gomarasca P; Frova C; d'Atri G
    Arzneimittelforschung; 1986 Sep; 36(9):1369-71. PubMed ID: 3790188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors stimulating liver regeneration; role of anabolic steroids in reactive regeneration in chronic liver diseases].
    Nicolaescu T; Bordeianu A; Bittman E; Gabrielescu E; Stoiculescu P; Drăgulescu N
    Rev Roum Physiol; 1969; 6(2):119-26. PubMed ID: 5821595
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical findings on the therapeutic action of a long-acting anabolic agent.
    Luppino V
    Panminerva Med; 1965 Oct; 7(10):392-8. PubMed ID: 5320934
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies of the effect of a new anabolic agent in burned patients].
    Roman Calderon J
    Prensa Med Mex; 1968; 33(1):51-3. PubMed ID: 5760271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of aplastic anemia with mepitiostane (author's transl)].
    Toyama K; Kaneko J; Suzuki H; Negishi M; Nakada I; Tobita K; Katayama T
    Rinsho Ketsueki; 1979 Feb; 20(2):121-7. PubMed ID: 439410
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical results of a long-acting anabolic steroid, oxynosterone cypionate (TBS) in pediatrics].
    Matsumura T; Uehara Y; Ebina T
    Nihon Rinsho; 1968 Dec; 26(12):3522-7. PubMed ID: 5753032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proceedings: Clinical experience with administration of 2 alpha, 3 alpha- epithio-5 alpha-androstan-17 beta- yl, 1-methoxy-cyclopentyl ether (10364-S) in breast diseases].
    Izuo M; Okada T; Suemasu K; Fujimori M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):509. PubMed ID: 4476537
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with anabolic steroid therapy in osteoporosis].
    Müller G
    Z Arztl Fortbild (Jena); 1973 Mar; 67(6):277-9. PubMed ID: 4716646
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the local activity of an anabolizing agent in the repair processes of cutaneous lesions. Clinical study].
    Marpillero P; Dani F
    Minerva Dermatol; 1968 Apr; 43(4):182-4. PubMed ID: 5741628
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimentation with 2-formyl-17(alpha)-methylandrosta-1,4-dien-11(alpha), 17(beta)-diol-3-one in geriatric clinic].
    Piatti N; Pozzi G
    Clin Ter; 1975 Jul; 74(2):144-66. PubMed ID: 770057
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen therapy.
    Longson D
    Practitioner; 1972 Mar; 208(245):338-48. PubMed ID: 4557109
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic effects of furazabol, (17-beta-hydroxy-17-alpha-methyl-5-alpha-androstane [2, 3-c] furazan, on experimental atherosclerosis in rabbits].
    Onodera T; Kasahara A; Ishihara M; Ogawa H; Oshima Y
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):458-69. PubMed ID: 5531414
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of osteoporosis with an enolic ether of dihydrotestosterone. (Clinical studies)].
    Domeniconi S
    Chir Organi Mov; 1966; 54(5):409-14. PubMed ID: 5333788
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the therapy of osteoporosis with anabolic steroids].
    Krüskemper HL
    Verh Dtsch Ges Inn Med; 1965; 71():590-6. PubMed ID: 5877670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.